G-tract RNA removes Polycomb repressive complex 2 from genes
Polycomb repressive complex 2 (PRC2) maintains repression of cell-type-specific genes but
also associates with genes ectopically in cancer. While it is currently unknown how PRC2 is …
also associates with genes ectopically in cancer. While it is currently unknown how PRC2 is …
Longitudinal surveillance of serum titanium ion levels in patients with indigenous 3D printed total temporomandibular joint replacement
G Khandelwal, A Roychoudhury, O Bhutia, A Shariff - Scientific Reports, 2023 - nature.com
The purpose of this longitudinal study was to surveil the serum titanium ion levels at various
time intervals in patients with indigenous 3D-printed total temporomandibular joint …
time intervals in patients with indigenous 3D-printed total temporomandibular joint …
Next-generation sequencing analysis and algorithms for PDX and CDX models
G Khandelwal, MR Girotti, C Smowton, S Taylor… - Molecular Cancer …, 2017 - AACR
Patient-derived xenograft (PDX) and circulating tumor cell–derived explant (CDX) models are
powerful methods for the study of human disease. In cancer research, these methods have …
powerful methods for the study of human disease. In cancer research, these methods have …
A phenomenological model for predicting melting temperatures of DNA sequences
G Khandelwal, J Bhyravabhotla - PloS one, 2010 - journals.plos.org
We report here a novel method for predicting melting temperatures of DNA sequences based
on a molecular-level hypothesis on the phenomena underlying the thermal denaturation of …
on a molecular-level hypothesis on the phenomena underlying the thermal denaturation of …
The combination of the PARP inhibitor olaparib and the WEE1 inhibitor AZD1775 as a new therapeutic option for small cell lung cancer
…, A Hughes, Z Lai, E Cadogan, G Khandelwal… - Clinical Cancer …, 2018 - AACR
Purpose: Introduced in 1987, platinum-based chemotherapy remains standard of care for
small cell lung cancer (SCLC), a most aggressive, recalcitrant tumor. Prominent barriers to …
small cell lung cancer (SCLC), a most aggressive, recalcitrant tumor. Prominent barriers to …
[HTML][HTML] Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study
…, G Bertolini, CL Hodgkinson, G Khandelwal… - Annals of …, 2016 - Elsevier
Background Over the past decade, numerous reports describe the generation and increasing
utility of non-small-cell lung cancer (NSCLC) patient-derived xenografts (PDX) from tissue …
utility of non-small-cell lung cancer (NSCLC) patient-derived xenografts (PDX) from tissue …
Inhibition of histone H3K27 demethylases inactivates brachyury (TBXT) and promotes chordoma cell death
Pharmacologic inhibition of H3K27-demethylases in human chordoma cells promotes epigenetic
silencing of oncogenic TBXT, alters gene networks critical to survival, and represents a …
silencing of oncogenic TBXT, alters gene networks critical to survival, and represents a …
[HTML][HTML] Disinfecting efficacy of three chemical disinfectants on contaminated diagnostic instruments: A randomized trial
…, P Tomar, R Gupta, G Khandelwal - Journal of basic and …, 2014 - ncbi.nlm.nih.gov
Aim: The aim was to compare the disinfecting efficacy of three chemical disinfectants on
contaminated diagnostic instruments. Settings and Design: This was a randomized, cross over …
contaminated diagnostic instruments. Settings and Design: This was a randomized, cross over …
Increased immune-regulatory receptor expression on effector T cells as early indicators of relapse following autologous stem cell transplantation for multiple myeloma
L Lee, N Alrasheed, G Khandelwal… - Frontiers in …, 2021 - frontiersin.org
The benefit of autologous stem cell transplantation (ASCT) in newly diagnosed myeloma
patients, apart from supporting high dose chemotherapy, may include effects on T cell function …
patients, apart from supporting high dose chemotherapy, may include effects on T cell function …
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics
…, S Gulati, MW Schenk, G Khandelwal… - British journal of …, 2019 - Wiley Online Library
Background and Purpose Small cell lung cancer (SCLC) is an aggressive disease with median
survival of <2 years. Tumour biopsies for research are scarce, especially from extensive‐…
survival of <2 years. Tumour biopsies for research are scarce, especially from extensive‐…